| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024110 |
| Receipt No. | R000027755 |
| Official scientific title of the study | Study of the effects of plant extract on skin surface temperature and blood flow |
| Date of disclosure of the study information | 2016/12/15 |
| Last modified on | 2017/09/21 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study of the effects of plant extract on skin surface temperature and blood flow | |
| Title of the study (Brief title) | Study of the effects of plant extract on skin surface temperature and blood flow | |
| Region |
|
|
| Condition | ||
| Condition | No | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the effects of plant extract on skin surface temperature and blood flow.
To investigation of interaction of plant extract with a food ingredient. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | skin surface temperature (First observation, Second observation, Third observation)
blood flow (First observation, Second observation, Third observation) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Capsules containing plant extract, single daily ingestion. | |
| Interventions/Control_2 | Capsules containing plant extract and a food ingredient, single daily ingestion. | |
| Interventions/Control_3 | Placebo capsules not containing plant extract and a food ingredient, single daily ingestion. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Individuals aged from 20 to 60 years, when giving the informed consent.
(2) Individuals who give the informed consents in writing, after receiving enough explanation of the purpose and details of the study, understanding the study well, and deciding to attend the study with their own will. |
|||
| Key exclusion criteria | (1) Individuals who are under treatment of some disease.
(2) Individuals who have possibility of allergy symptoms onset. (3) Individuals who are under treatment of skin disease (e.g., atopic dermatitis). (4) Individuals who are, or are under treatment, or have a history of serious disease (e.g., liver disease, kidney disease, heart disease) or/and thyroid gland disease, adrenal gland disease, and/or metabolic disorder. (5) Individuals who are pregnant or lactating. (6) Individuals who are planned to participate in other clinical study during this study periods. |
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Mika Miyake |
| Organization | Kirin Company, Limited |
| Division name | Research laboratories for health science & food technologies |
| Address | 1-13-5,Fukuura,Kanazawa-ku, Yokohama, Kanagawa, Japan |
| TEL | 045-330-9837 |
| m-miyake@kirin.co.jp | |
| Public contact | |
| Name of contact person | Mika Miyake |
| Organization | Kirin Company, Limited |
| Division name | Research laboratories for health science & food technologies |
| Address | 1-13-5,Fukuura,Kanazawa-ku, Yokohama, Kanagawa, Japan |
| TEL | 045-330-9837 |
| Homepage URL | |
| m-miyake@kirin.co.jp | |
| Sponsor | |
| Institute | Kirin Company, Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027755 |